New paper highlights the need for integrated digital behavioral support, proposing a "habit window hypothesis" and associated research agenda to maximize the long-term success of GLP-1 therapies
<p>TORONTO, Sept. 10, 2026 /PRNewswire/ -- Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant hurdles for many patients. A new viewpoint paper published in the Journal of Medical Internet...</p>
Read original article ↗
Related Articles
Gen Z Is Driving a Rebound in Brand Loyalty, New CivicScience Study Finds
Analysis of more than one million U.S. adults finds emotional connection, not price or quality, explains most of the dif
Workforce Concerns Are Emerging as a Barrier to AI Adoption in Collections, DROS Field Report Finds
Findings from conversations at ACA International's 2026 Annual Convention & Expo find the real barrier to deployment is
Company's Retail Ecosystem Boosts Scratch-Off Sales at 7-Eleven, Circle K and Kroger's Harris Teeter Locations Statewide
The ringleader of a cybercrime gang, which reportedly formed after meetups in Minecraft online, has plead guilty to a ra